Sunil Healthcare Limited

Sunil Healthcare Limited (SUNLOC) is a micro-cap Healthcare company valued at ₹72 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sunil Healthcare Limited last traded at ₹70, unchanged on the day.

Recent developments

On 2026-09-30, promoter holding remained at 73.53%, indicating no significant change in ownership. The latest quarter results, ending 2026-06-30, showed a sharp drop in net profit to ₹0 crore, compared to ₹1 crore in the same quarter a year earlier.

Financial performance

The company's annual revenue rose 5.2% to ₹88 crore, but the latest quarter's revenue fell 16.1% year-on-year to ₹19 crore. Net profit swung from a loss of ₹1 crore to a profit of ₹4 crore annually, with the net profit margin improving 6.3 percentage points to 4.6%. However, the latest quarter's net profit dropped 49.5% to ₹0 crore, highlighting a recent decline in profitability.

Valuation multiples

The stock trades at 17.9 times earnings, a discount to the Healthcare median of 32.0, 1.46 times book value.

Things to watch

The latest quarter's net profit fell 49.5% to ₹0 crore, raising concerns about recent performance. The company's profit has declined 15.6% annually over the past three years, and the latest quarter's revenue also fell 16.1% year-on-year. The stock is 14.6% below its 52-week high, indicating a recent pullback.

Where it stands

Sunil Healthcare Limited's annual net profit improved significantly, swinging from a loss to a profit, but the latest quarter's results show a sharp decline in profitability. The stock is 14.6% below its 52-week high, and the company's profit growth has slowed over the past three years. The latest quarter's net profit of ₹0 crore is the most significant figure reported.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.